Patient acceptable symptom state in scleroderma: results from the tocilizumab compared with placebo trial in active diffuse cutaneous systemic sclerosis

DSpace Repository

Patient acceptable symptom state in scleroderma: results from the tocilizumab compared with placebo trial in active diffuse cutaneous systemic sclerosis

Author: Arnold, Michael B.; Khanna, Dinesh; Denton, Christopher P.; van Laar, Jacob M.; Frech, Tracy M.; Anderson, Marina E.; Baron, Murray; Chung, Lorinda; Fierlbeck, Gerhard; Lakshminarayanan, Santhanam; Allanore, Yannick; Riemekasten, Gabriela; Steen, Virginia; Mueller-Ladner, Ulf; Spotswood, Helen; Burke, Laura; Siegel, Jeffrey; Jahreis, Angelika; Furst, Daniel E.; Pope, Janet E.
Tübinger Autor(en):
Fierlbeck, Gerhard
Published in: Rheumatology (2018), Bd. 57, H. 1, S. 152-157
Verlagsangabe: Oxford Univ Press
Language: English
Full text: http://dx.doi.org/10.1093/rheumatology/kex396
ISSN: 1462-0332
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)